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The retroviral integrase (IN) is a virus-encoded enzyme that is essential for insertion of viral DNA into the host chromosome. 
In order to map and define the properties of a minimal functional domain for this unique vira] enzyme, a series of N- and 
C-terminal deletions of both Rous sarcoma virus (RSV) and human immunodeficiency virus (HIV) INs were constructed. The 
RSV IN deletion mutants were first tested for their ability to remove two nucleotides from the end of a substrate representing 
the terminus of viral DNA in order to assess the contribution of N and C regions towards this reaction, referred to as 
processing. The results suggest that C-terminal amino acids of the intact RSV protein are required to maintain specificity 
of the processing reaction. Though deficient for processing, the RSV deletion mutants exhibited a secondary endonucleolytic 
activity that was indistinguishable from that of wild-type IN, demonstrating that all retained some enzymatic activity. RSV, 
and a larger set of HIV-1, IN deletion mutants were then tested for their ability to perform an intramolecular, concerted 
cleavage-ligation reaction using an oligodeoxynucleotide substrate that mimics the intermediate viral-host DNA junction 
found prior to the final step of covalent closure. The composite results from such analyses define a minimal functional 
central region of --140 amino acids for each enzyme that includes the highly conserved D,D(35)E domain. Results with HIV- 
1 and HIV-2 IN also indicate that the efficiency of concerted cleavage-ligation depends upon the presence of CA/GT base 
pairs within the viral component of the DNA substrate at the reaction site. Even the isolated central region of HIV-1 IN 
exhibited this sequence requirement for optimal activity. We conclude that this evolutionarily conserved central region of 
IN not only encodes residues that are required for the catalytic activity of the enzyme but also harbors some or all of the 
determinants responsible for recognition of the CA/GT dinucleotides that are present at the ends of all retroviral DNAs. 
© 1995 Academic Press, Inc. 
INTRODUCTION 
Integration requires the removal of (usually) two nucle- 
otides from the 3 r ends of retroviral DNA and subsequent 
joining of these recessed ends to host DNA. In a natural 
infection, the cleavage of viral DNA termini, referred to 
as the processing reaction, can occur in the cytoplasm 
as soon as viral DNA synthesis is completed (Roth etaL, 
1989). The subsequent covalent l inkage of the new 3' 
ends of viral DNA to host sequences, referred to as the 
joining reaction, takes place in the nucleus of the infected 
cell. The joining reaction is thought to occur by a con- 
certed c leavage- l igat ion mechanism in which the 3'-OH 
of viral DNA directly attacks an internal phosphate of 
host DNA (Engelman et aL, 1991). The mechanism by 
which the 5r-ends of viral DNA are joined to host DNA 
is unknown. In vitro, it has been shown that the retroviral 
encoded integrase (IN) is the only protein required for 
both processing and joining and that these two steps 
can be uncoupled biochemical ly (Craigie et aL, 1990; 
Katz et aL, 1990). An understanding of the mechanism of 
action of IN is of broad scientific interest, since several 
1To whom correspondence and reprint requests should be ad- 
dressed. 
features are shared with a number of recombinase sys- 
tems (Mizuuchi, 1992; Skalka, 1993). There is also practi- 
cal interest in this enzyme as a possible target for antivi- 
ral therapy. 
IN appears to be composed of at least three distinct 
domains (Khan etaL, 1991; Kulkosky etaL, 1992; Engel- 
man et aL, 1993). These include= (1) an N-terminal do- 
main, characterized by a putative Zn+2-finger motif, re- 
ferred to as the HHCC region, (2) a central domain, which 
includes three invariant acidic residues, referred to as 
D,D(35)E, and (3) the remaining carboxyl terminal portion 
which has been shown to have a high affinity for DNA 
(Khan et al., 1991; Woerner et aL, 1992; Vink et al., 1993). 
Amino acid sequence comparisons have revealed that 
the central domain is evolutionari ly conserved in the in- 
tegrases of retroviruses and retrotransposons and 
among certain transposases of bacterial insertion se- 
quence (IS) elements (Khan et al., 1991; Kulkosky et al., 
1992; Engeiman and Craigie, 1992). Single amino acid 
substitutions of the invariant Asp(D) or Glu(E) residues 
which characterize this domain dramatical ly reduce both 
processing and joining (Kulkosky et al., 1992; Drelich 
et aL, 1992; Engelman and Craigie, 1992). Thus, these 
activities are likely catalyzed by a single active site that 
includes the D,D(35)E domain. Studies with human im- 
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munodeficiency virus-1 (HIV-1) IN suggest that both the 
N- and C-terminal regions are also required for a produc- 
tive interaction with the normal DNA substrates; terminal 
deletions outside the D,D(35)E domain result in pro- 
cessing and joining defects (Drelich et al., 1992; Vink et 
aL, 1993). However, truncated versions of Rous sarcoma 
virus (RSV) and HIV-1 IN, which contained the central 
domain were recently shown to catalyze the cleavage- 
ligation reaction in a unimolecular substrate that mimics 
an intermediate in the first virus to host DNA joining 
event (Bushman et al., 1993; Bushman and Wang, 1994). 
In this report we describe the independent construc- 
tion and analysis of a series of truncated RSV and HIV- 
1 IN proteins. We show that the central domains of both 
can catalyze a concerted cleavage-ligation reaction in a 
unimolecular substrate that represents another integra- 
tion intermediate, which precedes the final step in cova- 
lent joining of the 5' end of viral DNAto the host genome. 
These and our previously reported results (Skalka, 1993) 
support the conclusion that the catalytic activities of both 
enzymes are contained within a central region of ~140 
amino acids, which includes the highly conserved 
D,D(35)E domain. Approximate boundaries of this region 
are estimated to be amino acids 52 and 207 for RSV IN 
and 58 and 201 for HIV-1 IN. Our analyses with HIV-1 
and HIV-2 INs also show that the efficiency of joining the 
5'-end of viral to "host" DNA is sequence-dependent and 
that even the isolated central D,D(35)E domain of HIV-1 
IN requires the conserved viral CA/GT base pairs in this 
substrate for optimal activity. 
MATERIALS AND METHODS 
Construction of RSV IN deletion mutants 
We have observed that certain C-terminal deletions of 
RSV IN are unstable when expressed in Escher/chia co//. 
This might be due to the presence of incomplete subdo- 
mains that would be targets for bacterial degradation 
enzymes. To avoid this problem, we decided to screen 
a population of plasmids in which the reading frame for 
the C-terminus was deleted to varying degrees. The start- 
ing plasmid, pRC231N, expresses RSV IN under control 
of the lambda PL promoter (Khan etaL, 1991). The plas- 
mid was linearized with Xhol which cleaves ca. 150 bp 
downstream of the IN termination codon and the linear 
DNA was treated with Ba/31 exonuclease for various 
lengths of time. The DNA was purified, religated, and 
used to transform E. co/i. We relied on the neighboring 
region of pBR322 to provide new termination codons. 
Twenty-four clonal cultures were examined for size and 
stability of the expressed protein. One clone produced a 
fragment of ca. 24 kDa that comprised ~>15% of the total 
bacterial cell protein. Nucleotide sequence analysis re- 
vealed that in this construct the codon for amino acid 
207 of IN was fused to two codons (Asp and Leu) from 
pBR322, followed by a termination codon. We refer to the 
protein produced by this construct as RSV IN 1-207. To 
create additional deletions at the N-terminus, the (1- 
207) expression plasmid was digested with EcoRI, which 
cleaves just 5' of the ATG for IN, plus either BspMI or 
Avrll, which cleave at unique sites in the HHCC domain 
coding region of the plasmid. The plasmids were re- 
sealed with an EcoRI/blunt linker composed of IN amino 
acids 1 through 4, plus the methionine initiation codon. 
Ligation of the blunt end of the linker to the repaired 
BspMI site reestablished the IN reading frame between 
codon 4-and codon 39. We refer to this construct as RSV 
IN 39-207. Similarly, ligation of the blunt-end of the linker 
to the repaired Avrll site reestablished the IN reading 
frame between codon 4 and codon 52. We refer to this 
construct as RSV IN 52-207. Deleted IN proteins were 
purified to homogeneity as previously described using 
an immunoaffinity column as the final step (Jones et al., 
1992). 
Construction of HIV-1 and HIV-2 IN expression 
plasmids, and IN protein purification 
The construction of the expression plasmid for the 
synthesis of wild-type, nonfused, HIV-1 IN protein has 
been reported (Bizub-Bender et aL, 1994). We have also 
described the construction of the expression plasmid in 
which wild-type HIV-1 IN DNA sequences were fused to 
the 3' end of the E. coil gene encoding the maltose 
binding protein (MBP) (Kulkosky et aL, 1992). Various 
deletion mutants of HIV-1 IN, fused to MBP, were derived 
from this "parental" vector and some of these constructs 
have been described previously (Bizub-Bender et aL, 
1994). pMBP HIV-1 IN (58-170) and (58-154) constructs 
were made as follows. The parental vector was digested 
with Stul and Hindlll which cleave at the ends of the 
coding region. A PCR-generated fragment was then in- 
serted that contained a Stul site at its 5' end, followed 
by sequences encoding HIV-1 IN residues 58-170 or 
58-154 and a H/ndlll site at its 3' end. The 3' PCR 
primer included two additional codons for Phe, Ala, and 
an amber stop codon. Expression and purification of the 
MBP fusion proteins was performed as described pre- 
viously (Kulkosky et aL, 1992). The expression plasmid 
for the production of nonfused HIV-2 IN (pRP279) was 
kindly provided by Dr. Ronald Plasterk (Netherlands Can- 
cer Institute, Amsterdam, Netherlands). Purification of 
HIV-2 IN was as described (van Gent etaL, 1991) except 
that we observed a precipitate upon overnight dialysis 
prior to the butyl Sepharose chromatography step. After 
resolubilization of this precipitate, we obtained a prepa- 
ration of HIV-2 IN of approximately 80% purity which was 
suitable for use in the activity assays described below. 
Oligodeoxynucleotide assays for IN activity 
The RSV viral LTR processing assay was performed 
as described previously (Jones et aL, 1992). Reac- 
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tions to detect cleavage-ligation activity used a DNA 
substrate that required preannealing of three single- 
stranded oligodeoxynucleotides the sequences of which 
are as follows~ HIV-1 based substrate, (1) 5'-TGTGGA- 
AAATCTCTAGCA-I-IAAGGGTTT-3', (2) 5'-ACTGCTAGA- 
GAGA-Iqqq-CCACA-3'; RSV-based substrate, (3) 5'-GT- 
A-i-i-GCATAAGACTACATTAAGGG-1-1-i--3', (4) 5'-ACTG- 
TAGTCTTATGCAATAC-3'; random sequence-based, 
(5) 5'-Cqq-GAAGAATACGACGCTTAAGGG~q--3', (6) 5'- 
ACGCCGTCGTATTCTTCAAG-3'; common nonviral com- 
plementary strand; (7) 5'-AAACCCTTAA-3'. Equimolar 
amounts of each of the component single strands were 
dissolved in 50 mM NaCI, 10 mM Tris, pH 7.5, and 0.1 
mM EDTA at a concentration of 100 pmol/#l and heated 
to 95 ° for 2 min. The mixtures were then kept at room 
temperature overnight and finally incubated at 4 ° for 30 
min prior to addition to the reaction. For the HIV substrate 
oligodeoxynucleotides 1, 2, and 7 were annealed; for the 
RSV substrate 3, 4, and 7 were annealed; for the "Ran- 
dom" substrate 5, 6, and 7 were annealed. The nonviral 
sequences, meant to represent flanking host DNA in all 
of the substrates, are underlined. The cleavage-ligation 
reactions were performed in a total volume of 15 #l with 
a final concentration of 50 mM NaCI, 10 mMTris, pH 7.5, 
10 mM MnCI2, 6% DMSO, and 10 pmol each of substrate 
and protein. Incubation times are as indicated in the 
respective figure legends. We have demonstrated pre- 
viously that the prolonged incubation times required to 
generate product for the MBP fusion proteins fall within 
a linear range of the protein's activity (Kulkosky et al., 
1992). The reaction products were then separated in a 
20% denaturing acrylamide gel and visualized by autora- 
diography. 
RESULTS 
Effect of N- and C-terminal deletions on RSV I11 
processing activity 
In an attempt to delineate the catalytic domain of RSV 
IN, we prepared a series of C-terminal deletions by Ba131 
nuclease digestion. RSV IN (1-207), which is missing 
the C-terminal 79 amino acids, was chosen for further 
study because it was produced very efficiently in E. co~i, 
was present in the soluble portion of the cell extract, and 
retained the D,D(35)E region in addition to an adjacent 
downstream section (V156 to M177) suggested to con- 
tain an amphipathic helix of possible functional signifi- 
cance (Lin and Grandgenett, 1991). Figure 1 shows the 
results from assays of processing activity of wild-type 
RSV IN [wt(1-286)], RSV IN (1-207), and two N-terminal 
deletion derivatives [(39-207), (52-207)], using a duplex 
oligodeoxynucleotide substrate that represents the U3 
end of RSV DNA. The data (Fig. 1 B) show that full-length 
RSV IN produced the expected major -2  processed 
product that is derived from cleavage immediately 3' of 
the invariant CA dinucleotide present near both ends of 
all retroviral DNAs. Additional minor cleavages which are 
specifically inhibited by an mAB against RSV IN (data not 
shown) are also detected at other positions within the 
substrate, the most apparent at the -3  position. Reac- 
tions with equimolar amounts of purified RSV IN (1-207) 
and the two derivatives, (39-207) and (52-207), showed 
no -2  products. However, cleavage at the -3  site be- 
tween the C and A, which is characteristic of IN activity 
(Katzman eta/., 1989; B. M011er and A. M. Skalka, unpub- 
lished observations) as well as other minor cleavage 
products, was nearly identical to that of the full-length 
IN. These mutants are also defective in the joining reac- 
tion, as expected, since they produce no -2  processed 
product with the CA ends that are required for subse- 
quent joining to other substrate molecules (data not 
shown). 
These results suggest that the deletion mutants retain 
endonucleolytic'activity but are unable to position the 
viral DNA substrate properly for specific cleavage at 
the -2  site. This is consistent with earlier studies that 
suggested a role for C-terminal IN sequences in binding 
DNA (Khan et al., 1991; Woerner et al., 1992). In order 
to test whether these truncated versions of IN could 
perform a concerted cleavage-ligation reaction, we uti- 
lized a single, interrupted duplex substrate in which 
potentially reactive groups were juxtaposed, as de- 
scribed below. 
Intramolecular cleavage-ligation by RSV and HIV-1 
IN deletion mutants 
Chow et al. (1992) originally reported that HIV-1 IN 
can catalyze a concerted cleavage-ligation reaction on 
a variety of DNA substrates. The prototypic substrate 
mimicked the "Y-intermediate" formed when either 3'- 
end of viral DNA attacks an internal phosphate in the 
target DNA. HIV-1 IN was able to release the viral DNA 
and reseal the target DNA in a reaction thought to in- 
volve a direct attack on the internal phosphate at the 
junction of viral and "host" sequences by the 3'-OH end 
of the host DNA strand. However, the viral sequence, 
present as one arm of the Y-intermediate, was not abso- 
lutely essential; a single unpaired A nucleotide was suf- 
ficient for detectable activity (Chow et al., 1992). The 
biological relevance of this reaction is unknown. 
The "Y" type substrate we chose to test was designed 
to resemble the end of a partially integrated provirus in 
which the 3'-end is already covalently joined, the gap 
of host DNA filled in, and the unhybridized 5' dinucleo- 
tides of viral DNA net yet removed (see Fig. 2 left). It 
has generally been assumed that host cell enzymes are 
responsible for the DNA repair activity involved in these 
final steps of integration. However, the activity of IN on 
substrates described above had suggested that com- 
bined action of retroviral reverse transcriptase (RT) and 
IN could also perform these functions in vivo (Chow et 
aL, 1992; Sherman et aL, 1992). 
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A Structure of RSV IN Deletion Mutants 
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FIG. 1. Structures and processing activities of RSV {N deletion mutants. (A) On the left, the structures of fulHength, wild-type (wt), and three 
deletion mutants are depicted• HHCC denotes conserved his and cys residues in the Zn +2 fingerqike motif at the N-terminus. The approximate 
location of invadant Asp (D) and Glu (E) residues are shown in the highly conserved central region of iN referred to as the D,D(35)E domain• Vertical 
dashed lines indicate the approximate boundaries of this domain. The adjacent striped area indicates the }ocation of a putative amphipathic 
helix. The open region depicts the C4erminal domain whose sequence is not conserved among retreviral INs of different origin. The duplex DNA 
substrate, representing the U3 end of RSV DNA is illustrated at the right• Vertical arrows show the expected sites for cleavage by the full-length 
protein. The asterisk shows the position of the radiolabel (~P). (B) Processing reactions using equimolar amounts of wild-type and truncated proteins 
shown in A. Reactions were incubated for increasing lengths of time under conditions described under Materials and Methods• Lanes are as 
follows in each group: no protein, 4-, 8-, 16-, and 32-min incubations• Products were separated on a 20% denaturing sequencing gel and visualized 
by eutoradiography. The arrow marked S shows the position of the 32p-labeled substrate strand. Other arrows show the pesitions of products that 
are shorter by 1(- 1), 2(- 2), or 3(- 3) nucleotides. 
The results in Fig. 2 show that ful l - length RSV IN, like 
HIV-1 IN (Sherman eta / . ,  1992), can perform a concerted 
c ieavage- l igat ion reaction on such a substrate. In this 
case, the labeled duplexed 10 mer is joined to the neigh- 
boring strand to produce a product that is 28 nt in length 
(Figs. 2A and 2B). Direct chemical  sequencing of this 
product, purif ied from the gel, confirmed that the two 
unpaired 5' overhand nucleot ides were removed during 
this joining reaction (data not shown). 
The truncated versions of the RSV IN protein also 
produce the joined product and appeared in this set of 
reactions to accumulate more of it than the ful l - length 
protein• However, in other compar isons their  activity 
was essential ly equivalent to that of wi ld type and care- 
ful rate measurements would be required to determine 
the relative activit ies of these proteins. Other major re- 
action products of 19, 20, and 21 nucleot ides in length 
are also apparent in Fig, 2B. Chemical sequencing of 
these addit ional products indicates that they, too, were 
initially generated by the same c leavage- l igat ion  reac- 
tion that produced the major labeled 28-nt product. The 
reduced lengths of these three most prominent frag- 
ments apparently result from subsequent endonucieo-  
lytic cleavage. These secondary nicks cluster between 
or are immediately adjacent to a TA sequence in the 
viral-derived portion of the 28-nt product (data not 
shown). 
In order to determine if this c leavage- l igat ion activity 
was a general feature of the retroviral integrase central 
domains, we examined the activity of HIV-1 IN and analo- 
gous deletion mutants in the same type of assay. The 
HIV-1 protein and its derivatives were constructed as 
fusions to MBP as il lustrated in Fig. 3. Full-length MBP 
HIV-1 iN (Fig. 4) produces the expected 28rot product 
from an HIV-1 substrate analogous to that used with RSV 
IN. Truncated HIV-1 IN (58-201), analogous to RSV IN 
(55-207), was also able to carry out the c leavage- l iga-  
tion reaction, but at reduced efficiency compared to wild 
type. Thus, unlike RSV IN, the fuIHength HIV protein pro- 
duced consistently more c leavage- l igat ien product than 
its truncated counterpart. These comparative differences 
may reflect an inherent difference in activity between 
HIV and RSV )N relative to their truncated forms. Larger 
deletions of HIV-1 IN, which either terminated at the end 
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FIG. 2. Cleavage-ligation activity of RSV IN deletion mutants• The structure of the oligodeoxynucleotide substrate is shown at the bottom left of 
the panel (sequences are provided under Materials and Methods)• Equimolar amounts (10 pmol) of substrate and protein were reacted for the 
times indicated below• The asterisk denotes the position of the radiolabel (32p) on the nonviral complementary strand (10 nt). N indicates that any 
of the four nucleotides should be acceptable at this position• The 10 met is joined by the action of IN to the neighboring stand via nucleophitic 
attack as illustrated by the arrow• This produces a 28-nt product whose mobility in a denaturing gel is indicated on the right• (A) 5-min reaction 
with the RSV IN proteins indicated. (B) 15-min reaction• 
of the putative amphipathic helix (58-170), or lacked this 
region entirely (58-154), were inactive in this assay. As 
expected, MBP alone (Fig. 4, lane 1) or fusion of MBP 
with a region that included only part of the D,D(35)E 
domain (lane 6), were also inactive. MBP RSV IN was 
included for comparison; this protein also produced a 
28-bp product with the HIV-1 substrate. However, under 
the conditions of this assay many smaller cleavage prod- 
ucts are observed With the RSV IN fusion and they appear 
to represent a more randomized collection of degrada- 
tion products than those generated by HIV-1 IN. Unlike 
fused RSV IN, the HIV-1 fusion appears to prefer cleaving 
at sites near the ends of the DNA substrate; the degrada- 
tion products cluster just below the size of the major 
cleavage and ligation product. 
Sequence dependence of the intramolecular 
cleavage-ligation reaction 
Little progress has been achieved in identifying the 
regions of IN that are responsible for sequence-specific 
recognition of viral DNA sequences. Such recognition is 
presumably required for the retroviral INs to process and 
join their cognate LTR ends with the appropriate specific- 
ity. Although MoMuLV IN can act upon HIV-1 LTR DNA 
ends with very low efficiency (Vink eta/., 1990), in general 
there appears to be little species crossover (Katzman et 
aL, 1989). Nevertheless, all retroviral DNA ends contain 
invariant CA/GT base pairs and it thus seemed possible 
that the conserved central region of IN that includes the 
D,D(35)E domain may be responsible for recognition of 
MBP HIV-1 INTEGRASE 
"Zinc finger" : D,D(35E) i AH 
i 
HHCC {D D E E 
~ ~ + - ~ ~ . ~ . ~  i 1-288 
[ ~  I 141-288 
!O D E} 
~ ~ + ~  J 58201 
iD D E i 
L, ~ ~ ~ + ~  58-170 
iD D E i 
o , .: ~,~::'1 58-154 
MBP RSVINTEGRASE 
HHCC D D E 
. . . . .  - -~  . . . . . . .  = . . . .  ~ I 1-286 
FIG, 3. Structure of HIV-1 IN and RSV IN fusion proteins. The maltose binding protein (MBP) portion of the fusion is depicted by the solid rectangle. 
Other conventions are as described in the legend to Fig. 1. Shown are MBP fused with full-length (top) or segments of HIV-1 IN, or full-length RSV 
IN (bottom). The numbers on the right are positions of the amino acids that mark the endpoints of the IN components• 
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PRODUCT: 
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FIG. 4. Cleavage-ligation activity of HIV-1 IN deletion mutants. The structure of the oligodeoxynucleotide substrate is shown at the bottom left of 
the panel (sequence provided under Materials and Methods). Similar to the RSV reactions, equimelar amounts (10pmol) of substrate and HIV-1 IN 
were assayed. As in Fig. 2, the asterisk denotes the position of the radiolabel (32p) on the 10 mer. The 28 mer and other products of the reaction 
are produced by the proteins indicated above each lane from a 3-hr incubation which we have previously shown to be within a linear range of 
activity for the wt fusion protein (Kulkosky et al., 1992). 
this invariant signal. In order to determine if residues in 
this central domain could contribute to such recognition, 
we examined the effect of DNA sequence on the intramo- 
lecular c leavage- l igat ion reaction in our model sub- 
strates. The importance of the CA/GT bp was tested in 
two ways, (1) by altering the CA/GT bp in the context of 
the standard HIV-1 DNA substrate and (2) by introducing 
a CA/GT bp into an otherwise random sequence of simi- 
lar structure (Fig. 5). 
The c leavage- l igat ion reactions catalyzed by the HIV- 
1 IN fusions are shown in the four left panels (lanes 1-  
8) of Fig, 6. For the full- length HIV-1 IN fusion protein 
(1-288), product formation was most efficient with the 
HIV-1 LTR-based substrate that contained the normal 
CA/GT sequence. Utilization of the random substrate that 
contains this sequence was also observed, but the 
amount of product formed in this case was only ~20% of 
that observed with the normal HIVe1 LTR-based substrate 
(compare lanes 1 and 6). Product formation was barely 
detectable with either substrate if the CA/GT base pair 
was altered (lanes 2 and 5). These results are consistent 
with a number of earlier studies of the processing and 
joining activities of HIV-1 IN which demonstrated that 
additional LTR sequences apart from the CA/GT contrib- 
ute to recognition of IN, but that this conserved dinucleo- 
tide is of major importance. Results with the truncated 
HIV-1 IN (58-201) were signif icantly different. This pro- 
tein was much less active in c leavage- l igat ion than the 
full- length IN with all substrates (consistent with results 
in Fig. 4). However, no difference in act iv i tywas observed 
between the normal HIV-1 LTR-based substrate and the 
random substrate that contained the CA/GT base pair 
(lanes 3 and 8). Thus, the deleted regions contribute both 
to the efficiency of the reaction and to recognition of LTR 
sequences apart from the CA/GT base pair. Little or no 
product was formed by the truncated protein when pre- 
sented with substrates that contained an altered dinucle- 
otide sequence (GA/CT or GC/CG). Thus, we conclude 
that the central core domain must play a role in recogni- 
tion of this highly conserved and critical LTR dinucleotide 
sequence. 
5 w 5 I 
A A 
C /~,~C 
, ,  . .o .  c 
"HOST DNA" HIV LTR END 
HIV LTR "CA" RANDOM "GC" 
51 5 I 
A A 
C C 
"HOST DNA" HIV LTR END 
HIV LTR "GA" RANDOM '*CA" 
FIG. 5. Critical features of cleavage-Jigation substrates. Two pairs of 
substrates are depicted with (left) and without (right) the viral sequence. 
Nuoleotide differences between each pair are as indicated. 
I HIV LTR'-~q 
CA GA CA GA 
N 
1 2 3 4 
MBP HIV MBP IN 
IN 58-201 
RANDOM - - - - [  
GC CA GO CA 
NN 
5 6 7 8 
MBP HIV MI3P IN 
IN 58-201 
f RANDOM~ 
GC CA GC CA 
9 10 11 12 
HIV-11N HIV-21N 
~-28nt  
FIG. 6. Oleavage-ligation activities of HIV-1 and HIV-2 IN proteins on 
test substrates. Conditions were as described in the legend to Fig. 4. 
The identity of the substrates and proteins used are provided at the 
top and bottom, respectively. Reactions withthe fusion proteins were 
incubated for 3 hr; nonfused HIV-1 and HIV-2 IN for 30 min. 
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In order to explore the generality of this sequence 
dependent reactivity, both RSV IN and HIV-2 INs were 
tested on the random sequence substrate with or without 
the CA/GT sequence. The RSV proteins were active on 
the random substrate with or without the CA/GT base 
pairs and no sequence-specificity preference was ob- 
served under the limited conditions tested (data not 
shown). However, as illustrated in the right panel of Fig. 
6, similar to nonfused HIV-1 IN, even a partially purified 
nonfused form of wild-type HIV-2 IN showed the same 
preference for the random sequence with the CA/GT 
base pairs despite the apparent presence of a contami- 
nating endonuclease responsible for some degradation 
of the major product. The ratio of 28 nucleotide products 
from the "CA" versus "GC" substrate appears less for the 
nonfused proteins than the MBP fusion (compare lanes 
5 and 6 with 9 and 10). However, this probably represents 
an underestimate for the HIV-1 IN reaction since some 
product is lost by cleavage of the 28 nucleotide product 
at an internal TA dinucleotide (illustrated by the lower 
band in lane 10). This by-product of the reaction appears 
to be produced more readily by the nonfused HIV-1 IN 
(Fig. 6, compare lanes 1 and 10). 
DISCUSSION 
IN must catalyze two distinguishable reactions, re- 
ferred to as processing and joining, in order to integrate 
retroviral DNA. Mutagenesis (Kulkosky eta/., 1992; Drel- 
ich et aL, 1992; Engelman and Craigie, 1992; Katz et 
aL, 1992) and complementation studies (Engelman et aL, 
1993; van Gent et aL, 1993) indicate that these activities 
are catalyzed at a common active site. Furthermore, the 
fundamental mechanism underlying processing and join- 
. ing seems to bethe same; both appear to require nucleo- 
philic attack on a DNA phosphodiester bond. For pro- 
cessing, the oxygen of a water molecule is assumed to 
be the primary nucleophile in vivo; removal of the terminal 
nucleotides from the viral DNA is accomplished by hydro- 
lysis. For joining, the oxygen of the 3'-OH group at the 
end ofthe processed viral DNA serves as the nucleophile 
(Engelman et al., 1991). 
/n vitro assays have been used to elucidate the mecha- 
nism of IN function described above and these assays 
typically employ short duplex oligodeoxynucleotide sub- 
strates which represent either free end of the viral DNA 
(Katzman et al., 1989). The reactions described in this 
report also utilized synthetic DNA substrates; however, 
product formation for most of the assays depends upon 
the ability of IN to perform a concerted intramolecular 
cleavage-ligation reaction between two adjacent DNA 
strands in which the chemically reactive groups are jux- 
taposed. 
Cleavage-ligation seems to be most efficient with a 
"disintegration" substrate that is modeled after the inter- 
mediate produced by joining the end of one strand of 
a double-stranded oligodeoxynucleotide representing a 
single LTR end into another double-stranded target DNA 
(Chow et al., 1992). The substrate we tested mimics an- 
other potential intermediate--that in the final step of 
integration which involves the covalent joining of the 5' 
ends of the viral DNA to the host cell target. This reaction 
includes sealing of a nick and removal of a 2-nt overhang 
on the strand opposite the initial joining of the 3' ends 
of viral DNAto the host DNA. Sherman etaL (1992) have 
reported that wild-type HIV-1 IN can accomplish such a 
reaction. We confirm their finding and demonstrate that 
other retroviral INs can also catalyze such a reaction. 
However, the significance of this reaction in the context 
of the viral life cycle remains unclear, since the percent- 
age of conversion of substrate to product by three differ- 
ent retroviral INs, at least in vitro, is extremely low (gener- 
ally 0.2 to 1%). It is possible that other viral or host pro- 
teins provide abcessory functions that enhance this 
activity of IN in vivo. Alternatively, as had been presumed 
earlier, host repair enzymes may complete the integra- 
tion reaction without the involvement of viral compo- 
nents. In any case, a comparison of the activities of a 
series of RSV and HIV-1 IN deletion mutants on such a 
substrate has allowed us to (1) delineate the catalytic 
regions of RSV (52-207) and HIV-1 IN (58-201) and 
(2) assign at least part of the sequence-specificity of 
substrate recognition to the minimal catalytic domain of 
HIV IN. 
Region of IN important for processing and joining 
activities 
A simple model would suggest that the central domain 
of IN is involved in catalysis, while the terminal domains 
might play a role in recognition of viral and host DNAs. 
Previous deletion mutagenesis studies have demon- 
strated that removal of either terminal domain signifi- 
cantly reduces processing and joining (Drelich et al., 
1992; Bushman et aL, 1993; Vink et aL, 1993). However, 
the central region of IN containing the D,D(35)E domain 
is critical for both. This suggests that one or both of the 
IN terminal domains provide some auxiliary functions, 
but the exact nature of these functions have not been 
defined. 
In this report we show that deletion of the noncon- 
served C-terminal domain of RSV IN causes a defect in 
processing of the viral DNA substrate, but does not affect 
a secondary endonuclease activity of the protein. Thus, 
the C-terminus of IN may playan important role in the 
positioning of this substrate for appropriate cleavage in 
the catalytic site of the central D,D(35)E domain. Removal 
of the HHCC region from the RSV C-terminal deletion 
mutant had little or no additional effect upon (1) cleavage 
of the viral DNA substrate at secondary sites or (2) 
the intramolecular concerted cleavage-ligation activity. 
These observations leave the role of the HHCC region 
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in IN function in question. We have shown previously 
that single amino acid substitutions and deletions within 
the HHCC region of RSV IN do not affect the specificity 
of processing and joining reactions although they do 
lead to reduced activity under certain reaction conditions 
(Khan et aL, 1991; Katz et al., manuscript in preparation). 
In contrast, mutations in the HHCC region of HIV-1 IN 
seem to severely compromise processing as well as join- 
ing activities, and most recently have been reported to 
lead to a complete loss in sequence-specific recognition 
of viral sequences (Hazuda et al., 1994). Given these 
contrasting results, it seems possible that the HHCC re- 
gion may not be required for catalytic activity of IN nor 
recognition of viral LTR sequences, but is important for 
establishing and maintaining the tertiary structure of the 
protein in a conformation necessary for optimal IN func- 
tion. This interpretation is supported by a recent report 
describing the enzymatic activities of RSV IN N-terminal 
deletion mutants (Bushman and Wang, 1994; Katz et al., 
manuscript in preparation). 
Boundaries and specificites of the D,D(35)E catalytic 
domain 
Using the model intermediate DNA substrate, we 
tested truncated forms of both RSV and HIV-1 IN to define 
the limits of the functional central catalytic domain. In 
both cases the boundaries appear to lie just upstream 
of the first invariant D of the D,D(35)E region and just 
downstream of a putative amphipathic helix. This corre- 
sponds to residues 52 to 207 in RSV IN and 58 to 201 
for HIV-1 IN. We, and others, have observed that removal 
of additional amino acids from the C-terminal side of HIV- 
1 IN produces significant reduction in the activity of this 
core region (Bushman et al., 1993; Vink et aL, 1993). 
The intrinsic endonucleolytic activity on comparable 
substrates appears to be much greater for RSVthan HIV- 
1 IN. This difference may reflect enhanced binding of 
DNA by RSV IN, due to the presence of a high affinity 
site within the D,D(35)E domain of RSV IN (Khan et aL, 
1991; J. Kulkosky and A. M. Skalka, unpublished results). 
Smaller fragments observed as by-products in the con- 
certed cleavage-Iigation assay are derived from the 28- 
nt product and reflect this endonucleolytic activity of RSV 
IN. Chemical sequencing of these fragments revealed a 
preference for cleavage at an internal TA dinucleotide. 
We observed a similar propensity for cleavage at this 
same sequence by the nonfused HIV-1 IN as well. Inter- 
estingly, this dinucleotide appears to be the exclusive or 
highly preferred target site for certain bacterial IS ele- 
ments, specific Tc elements of C. elegans, and Tcl-l ike 
elements found in arthropods and vertebrates (van 
Luenen and Plasterk, 1994). Cleavage at this site by both 
RSV IN and HIV-1 IN may also be related to a similar 
preference in recognition of the CA/GT dinucleotide. 
Finally, our results demonstrate that the isolated HIV- 
1 iN central catalytic domain acts preferentially on cleav- 
age-l igation substrates that contain a CA/GT dinucleo- 
tide. This suggests a direct role for this domain in recog- 
nition of the conserved dinucleotide at the ends of viral 
DNA. This same dinucleotide is found at the ends of a 
number of bacterial IS elements (Galas and Chandler, 
1989). The transposases of one class of such elements 
also contain a region that is highly homologous to the 
D,D(35)E catalytic domain of retroviral and retrotranspo- 
son IN proteins (Khan eta/., 1991; Kulkosky eta/., 1992). 
The results reported here provide the first evidence for 
sequence specific recognition by an isolated domain of 
IN and may explain the coconservation of these two fea- 
tures for certain transposable elements. 
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